Delivery Order SPE2DB22D2211-SPE2DB24FNNB2
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,674.74, is for the supply of TUKYSA 150 MG TABLET with a completion date of December 10, 2024. It is a firm fixed-price contract and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product TUKYSA 150 MG TABLET UU 60S. The $12,251.30 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $36,753.90 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564608701 TUKYSA 150 MG TABLET UU 60S, with a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award, which is not set aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $36,820.50 firm fixed-price contract is for the delivery of the pharmaceutical product TUKYSA 150 MG TABLET UU 120S, with a completion date of October 7, 2024. The contract is not set aside for any specific business type. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, supporting various agencies and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,251.30 firm fixed-price delivery order is for the supply of 4566182677 - TUKYSA 150 MG TABLET UU 60S. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Delivery Order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00 through December 2025. The contract is for the delivery of the prescription drug TUKYSA 150 MG TABLET in quantities of 120 tablets, with a Firm Fixed Price of $24,547.00 and a completion date of June 28, 2024. This award does not...
- This federal contract award, valued at $12,697.69, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TUKYSA 150 MG TABLET, a medical product, with a completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract by the Defense Logistics Agency (DLA) worth $24,502.60 for the supply of TUKYSA 150 MG TABLET medication. The contract has a firm fixed price pricing type and a completion date of March 6, 2024. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $12,251.30, is for the delivery of the prescription drug TUKYSA 150 mg tablet. The contract is a Firm Fixed Price Delivery Order, with a period of performance through May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FNNB2Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,251.30 contract is for the supply of TUKYSA 150 MG TABLET, a pharmaceutical product, to support DLA's medical supply requirements. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of medications and medical supplies to the Department of Defense. This specific award is not designated as a set-aside contract. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 5/17/24 |